Missing data analyses [Regulatives / Guidelines]

posted by Astea – Russia, 2016-04-11 12:33 (3727 d 08:48 ago) – Posting: # 16182
Views: 7,350

Dear all!

Recently I've received a letter from the Customer where it was pointed out that according to the planning regulatory documents we have to include missing data in analyses in a very specific way. For example in several cases the missing data from one volunteer in one period should be replaced be the mean arithmetic of the other's data.

Of course this method has a right to exist. It was described in European Pharmacopeia 5.0 p.3.2.6 and in several articles, but it seems to me very strange to use this technic in bioequivalence data analyses.:confused:

Looking forward for your points of view!

"Being in minority, even a minority of one, did not make you mad"

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
165 visitors (0 registered, 165 guests [including 30 identified bots]).
Forum time: 21:22 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5